91 related articles for article (PubMed ID: 12743532)
1. Psychooncology and cancer progression-related alterations of pleasure-associated neurochemical system: Abnormal neuroendocrine response to apomorphine in advanced cancer patients.
Lissoni P; Malugani F; Manganini V; Ardizzoia A; Gardani G; Bartolacelli E; Messina G; Tancini G
Neuro Endocrinol Lett; 2003; 24(1-2):50-3. PubMed ID: 12743532
[TBL] [Abstract][Full Text] [Related]
2. A psychoneuroendocrine study of brain dopaminergic sensitivity in locally limited or metastatic cancer patients.
Lissoni P; Messina G; Vaghi M; Bartolacelli E; Massarenti LL; Trabattoni P; Meregalli P; Meregalli M; Gavazzeni C; Rovelli F; Tancini G; Gardani GS
In Vivo; 2003; 17(6):647-50. PubMed ID: 14758733
[TBL] [Abstract][Full Text] [Related]
3. A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients.
Messina G; Lissoni P; Bartolacelli E; Tancini G; Villa S; Gardani GS; Brivio F
J Biol Regul Homeost Agents; 2003; 17(4):322-6. PubMed ID: 15065761
[TBL] [Abstract][Full Text] [Related]
4. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
[TBL] [Abstract][Full Text] [Related]
5. Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems.
Lissoni P; Messina G; Brivio F; Rovelli F; Di Fede G; Mainini E; Veronese E
J Biol Regul Homeost Agents; 2005; 19(3-4):141-4. PubMed ID: 16602629
[TBL] [Abstract][Full Text] [Related]
6. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.
Lissoni P; Malugani F; Brivio F; Piazza A; Vintimilla C; Giani L; Tancini G
Neuro Endocrinol Lett; 2003; 24(3-4):259-62. PubMed ID: 14523367
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine alterations in lung cancer patients.
Mazzoccoli G; Carughi S; De Cata A; La Viola M; Giuliani A; Tarquini R; Perfetto F
Neuro Endocrinol Lett; 2003; 24(1-2):77-82. PubMed ID: 12743538
[TBL] [Abstract][Full Text] [Related]
8. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone response to low-dose apomorphine in restless legs syndrome.
Happe S; Bachmann CG; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
Growth Horm IGF Res; 2007 Aug; 17(4):323-7. PubMed ID: 17512770
[TBL] [Abstract][Full Text] [Related]
10. Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression.
Brivio F; Fumagalli L; Fumagalli G; Pescia S; Brivio R; Di Fede G; Rovelli F; Lissoni P
In Vivo; 2010; 24(2):239-41. PubMed ID: 20364003
[TBL] [Abstract][Full Text] [Related]
11. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia.
Viganò D; Lissoni P; Rovelli F; Roselli MG; Malugani F; Gavazzeni C; Conti A; Maestroni G
Neuro Endocrinol Lett; 2001 Apr; 22(2):137-41. PubMed ID: 11335890
[TBL] [Abstract][Full Text] [Related]
12. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
[TBL] [Abstract][Full Text] [Related]
13. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
Mussi C; Angelini C; Crippa S; Caprotti R; Fumagalli L; Motta V; Uggeri F
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxviii-ccxxxi. PubMed ID: 15244187
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretion.
Lissoni P; Vigano P; Vaghi M; Frontini L; Giuberti C; Manganini V; Casu M; Brivio F; Niespolo R; Strada G
Anticancer Res; 2005; 25(5):3597-9. PubMed ID: 16101186
[TBL] [Abstract][Full Text] [Related]
15. Effects of mental stress on cardiovascular and endocrine response in Air Force Academy cadets.
Falaschi P; Proietti A; De Angelis C; Martocchia A; Giarrizzo C; Biselli R; D'Urso R; D'Amelio R
Neuro Endocrinol Lett; 2003; 24(3-4):197-202. PubMed ID: 14523357
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia.
Lissoni P; Mandalà M; Giani L; Malugani F; Secondino S; Zonato S; Rocco F; Gardani G
Neuro Endocrinol Lett; 2000; 21(5):405-408. PubMed ID: 11452236
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals.
Fahlke C; Berggren U; Berglund KJ; Zetterberg H; Blennow K; Engel JA; Balldin J
Alcohol Clin Exp Res; 2012 Jan; 36(1):97-103. PubMed ID: 21797890
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women--a preliminary study.
Craig MC; Cutter WJ; Wickham H; van Amelsvoort TA; Rymer J; Whitehead M; Murphy DG
Psychoneuroendocrinology; 2004 Nov; 29(10):1309-16. PubMed ID: 15288710
[TBL] [Abstract][Full Text] [Related]
19. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease.
Lissoni P; Brivio F; Rovelli F; Fumagalli G; Malugani F; Vaghi M; Secondino S; Bucovec R; Gardani GS
J Biol Regul Homeost Agents; 2000; 14(4):275-7. PubMed ID: 11215816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
